Brianna Gerber

Brianna Gerber

Former Chief Financial OfficeratNiagen Bioscience· In proxies 2022–2024

Pay in FY2024-35% from the year before · Niagen Bioscience stock +271.0% the same year

Brianna Gerber was paid $451.0K in FY2024 (Dec), down 35%. Niagen Bioscience stock rose 271.0% that year.

Pay$100 in the stock at the end of FY21 → $142
Pay is from the Summary Compensation Table of each Niagen Bioscience proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Niagen BiosciencePublic company · 4 yr
    • Former Chief Financial Officer2022 – Present · 4 yrStock in role -37%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?